B16-BL6 Syngeneic Model

Synonyms: B16-BL6 melanoma cell line, B16-BL6 skin tumor cells

B16-BL6 is a widely studied cancer cell line derived from murine skin melanoma. It is frequently utilized in skin cancer research due to its aggressive tumorigenic behavior and relevance to melanoma studies. B16-BL6 cells provide a valuable model for investigating tumor progression, metastasis, and therapeutic interventions in melanoma. They have contributed significantly to our understanding of melanoma biology, drug discovery, and immunotherapy. The B16-BL6 cell line serves as an important tool for studying the molecular mechanisms underlying skin cancer and developing innovative treatment strategies.

Model Details

Cancer Type: Skin Cancer
Model Name: B16-BL6
Mouse Strain: C57BL/6
Treatment Data Available: aPD-1, aCTLA-4, Chemotherapy

B16-BL6 Growth Curve: Response to aCTLA-4, aPD-1, and Cyclophosphamide

Growth of subcutaneous B16-BL6 in C57BL/ 6 (n=10). Response to aCTLA-4, aPD-1, and Cyclophosphamide

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content